Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.
暂无分享,去创建一个
F. Ricci | M. Nichelatti | R. Cairoli | A. Tedeschi | S. Veronese | A. Colosimo | B. Scarpati | M. Montillo | E. Morra | M. Regazzi | S. Miqueleiz | M. Montagna | L. Intropido | Anna Colosimo